Integrating Metabolomics and Network Pharmacology to Explore the Protective Effect of Ginsenoside Re against Radiotherapy Injury in Mice

<table class="table-group" id="tab6"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Related pathways</td><td class="align_center">Related target gene</td><td class="align_center">Related metabolites</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Linoleic acid metabolism</td><td class="align_center">PLA2G2A</td><td class="align_center">Linoleic acid</td></tr><tr><td class="align_left">Fatty acid biosynthesis</td><td class="align_center">PPP5, ROCK1, ROCK2, AKT1, AKT2, CDK2, MAPK8, EGFR, IGF1R, CSF1R, NTRK2, NTRK1, SRC, SYK</td><td class="align_center">Palmitic acid, dodecanoic acid, myristic acid</td></tr><tr><td class="align_left">Glutathione metabolism</td><td class="align_center">GSR</td><td class="align_center">Oxidized glutathione</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Information on key target genes, metabolites, and metabolic pathways.</div>

Evidence-Based Complementary and Alternative Medicine

tab6

Table 6

Table 6: Integrating Metabolomics and Network Pharmacology to Explore the Protective Effect of Ginsenoside Re against Radiotherapy Injury in Mice 